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Flavokawain B (FKB) is a naturally occurring chalcone that can be isolated through the root 
extracts of the kava-kava plant (Piper methysticum). It can also be synthesized chemically to 
increase the yield. This compound is a promising candidate as a biological agent, as it is 
reported to be involved in a wide range of biological activities. Furthermore, FKB was reported 
to have antitumorigenic effects in several cancer cell lines in vitro. However, the in vivo 
antitumor effects of FKB have not been reported on yet. Breast cancer is one of the major 
causes of cancer-related deaths in the world today. Any potential treatment should not only 
impede the growth of the tumor, but also modulate the immune system efficiently and inhibit 
the formation of secondary tumors. As presented in our study, FKB induced apoptosis in 4T1 
tumors in vivo, as evidenced by the terminal deoxynucleotidyl transferase dUTP nick end 
labeling and hematoxylin and eosin staining of the tumor. FKB also regulated the immune 
system by increasing both helper and cytolytic T-cell and natural killer cell populations. In 
addition, FKB also enhanced the levels of interleukin 2 and interferon gamma but suppressed 
interleukin 1B. Apart from that, FKB was also found to inhibit metastasis, as evaluated by 
clonogenic assay, bone marrow smearing assay, real-time polymerase chain reaction, western 
blot, and proteome profiler analysis. All in all, FKB may serve as a promising anticancer agent, 
especially in treating breast cancer. 
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